Did management answer the analysts?
12 analyst questions audited.
View Claim Ledger →Camlin Fine Sciences reported FY26 revenue of ₹1,723 crore, impacted by ~20% shipment delays due to geopolitical disruptions.
✓ Verified against BSE filing
Camlin Fine Sciences reported FY26 revenue of ₹1,723 crore, impacted by ~20% shipment delays due to geopolitical disruptions. The blends business grew 17% (18% including discontinued Europe), missing the 20% target due to Winpai liquidity issues. Vanillin realizations improved to $12.5/kg in Q4 from $11, with tariffs reduced to 15.5% in the US. Management maintained FY27 guidance of ₹2,200-2,400 crore revenue and 12-14% EBITDA margins, driven by vanillin volumes of 4,000-4,200 MT and blends scaling to ₹1,400 crore. Key risks include lingering logistics disruptions, rising raw material costs (phenol up from ₹85 to ₹150/kg), and potential cash flow stress from extended working capital cycles.
कैमलिन फाइन साइंसेज ने वित्त वर्ष 2026 में ₹1,723 करोड़ का राजस्व दर्ज किया, जो भू-राजनीतिक समस्याओं के कारण करीब 20% शिपमेंट में देरी से प्रभावित हुआ। ब्लेंड्स कारोबार 17% बढ़ा (यूरोप बंद होने के बाद 18%), लेकिन विनपाई की नकदी समस्या के कारण 20% का लक्ष्य नहीं पहुंचा। वैनिलिन की कीमत चौथी तिमाही में $11 से बढ़कर $12.5/किग्रा हो गई, और अमेरिका में टैरिफ घटकर 15.5% रह गया। प्रबंधन ने वित्त वर्ष 2027 के लिए ₹2,200-2,400 करोड़ राजस्व और 12-14% EBITDA मार्जिन का लक्ष्य रखा है, जो 4,000-4,200 मीट्रिक टन वैनिलिन और ₹1,400 करोड़ के ब्लेंड्स पर आधारित है। मुख्य जोखिमों में लॉजिस्टिक्स में देरी, कच्चे माल की बढ़ती लागत (फिनॉल ₹85 से ₹150/किग्रा) और लंबे कार्यशील पूंजी चक्र से नकदी पर दबाव शामिल हैं।
12 analyst questions audited.
View Claim Ledger →Logistics disruptions and rising freight costs
View Risks →Full transcript text is available on this route.
Read Transcript →Q4 vanillin volume was 320-321 MT, up from ~200 MT in Q3, driven by channel stock liquidation.
Blends grew 17% YoY to ₹1,050 crore, missing 20% target due to Winpai liquidity issues.
Ethile vanillin campaign of 600 MT has 50% order book coverage already secured.
Catacol inventory of 3,000 MT provides buffer for vanillin production amid geopolitics.
Blends revenue is expected to cross ₹1,400 crore in FY27, with Winpai and Beta4 turning EBITDA positive.
Management expects consolidated revenue between ₹2,200 and ₹2,400 crore for FY27, driven by vanillin volume recovery and blends growth.
Management targets EBITDA margins of 12-14% for FY27, supported by vanillin margin improvement and cost control.
Management expects vanillin sales volume of 4,000-4,200 MT in FY27, with US volumes of 2,200-2,400 MT.
VPI (₹12-13 crore/month) and Vitafor (€12-13 million annual) are expected to grow 40-50% in FY27 through market expansion.
Geopolitical tensions have extended shipping times to 40-50 days and tripled freight costs, impacting working capital and sales execution.
Phenol prices have surged from ₹85 to ₹150/kg due to the conflict, increasing vanillin production costs by ~$1.5-2/kg.
Longer delivery times and liquidity crunch at Winpai have strained cash flows; management may need additional debt or equity.
Solvay is pricing vanillin at $17-18/kg to gain market share, limiting Camlin's ability to raise prices despite tariff reductions.
If the US-India trade deal is not signed, vanillin realizations may remain at $12.5/kg instead of improving to $14-15/kg, impacting margins.
The fire at the Brazil blending unit caused ₹33 crore loss; insurance survey is pending and recovery timeline is uncertain, potentially impacting Q4 results.
If the court does not approve liquidation by February 26, the cash bleed of ~₹8 crore per quarter from Europe could continue.
The TBHQ/BHA segment faces pricing pressure from local manufacturers, leading to margin compression and plateaued growth.
Management expects consolidated revenue between ₹2,200 and ₹2,400 crore for FY27, driven by vanillin volume recovery and blends growth.
Geopolitical tensions have extended shipping times to 40-50 days and tripled freight costs, impacting working capital and sales execution.
View Risks →